See All Slides - tctmd.com

Slides

Presentation TCT 2014

VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)_

Presenter: Jos? Mar?a Cubero G?mez

September 16, 2014

Presentation TCT 2014

Comparison between of Mitral Balloon Valvuloplasty and Surgical Commissurotomy for Mitral Valve Stenosis: Meta-Analysis of the Randomized Clinical Trials

Presenter: Daniel Garcia

September 16, 2014

Presentation TCT 2014

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Presenter: Alexander Plehn

September 16, 2014

Presentation TCT 2014

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Saibal Kar

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

Treatment of Rabbit Aneurysms with the Intracranial Multilayer Flow Modulator

Presenter: Edel Kavanagh

September 16, 2014

Presentation TCT 2014

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Presenter: Krishnankutty Sudhir

September 16, 2014

Presentation TCT 2014

3D Transesophageal Echocardiography provides optimal real-time guidance for off-pump, transapical implantation of artificial chordae tendineae_ An imaging study_

Presenter: Kestutis Rucinskas

September 16, 2014

Presentation TCT 2014

Novel Patient-based Finite Element Simulation Framework To Evaluate Fatigue Resistance Of Coronary Stent Design

Presenter: Peter Mortier

September 16, 2014

Presentation TCT 2014

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Presenter: Jacek Bil

September 16, 2014

Advertisement

Slides

VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)_

Comparison between of Mitral Balloon Valvuloplasty and Surgical Commissurotomy for Mitral Valve Stenosis: Meta-Analysis of the Randomized Clinical Trials

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Treatment of Rabbit Aneurysms with the Intracranial Multilayer Flow Modulator

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

3D Transesophageal Echocardiography provides optimal real-time guidance for off-pump, transapical implantation of artificial chordae tendineae_ An imaging study_

Novel Patient-based Finite Element Simulation Framework To Evaluate Fatigue Resistance Of Coronary Stent Design

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content